Evidence map›Paper›PMID 26756197›Full record

ArticleProtein science : a publication of the Protein Society2016

Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: Case study of PI4KIIIβ with Rab11.

Melissa L Fowler, Jacob A McPhail, Meredith L Jenkins, Glenn R Masson, Florentine U Rutaganira, Kevan M Shokat, Roger L Williams, John E Burke

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. MgbioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. ACS infectious diseases · 2021
    Review
  9. Review
  10. Article
  11. Dynamic structural biology at the protein membrane interface.The Journal of biological chemistry · 2019
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melissa L FowlerDepartment of Biochemistry and Microbiology, University of Victoria, British Columbia, V8P 5C2, Canada.
Jacob A McPhailDepartment of Biochemistry and Microbiology, University of Victoria, British Columbia, V8P 5C2, Canada.
Meredith L JenkinsDepartment of Biochemistry and Microbiology, University of Victoria, British Columbia, V8P 5C2, Canada.
Glenn R MassonMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, United Kingdom.
Florentine U RutaganiraHoward Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco (UCSF), California, 94158.
Kevan M ShokatHoward Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco (UCSF), California, 94158.
Roger L WilliamsMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, United Kingdom.
John E BurkeDepartment of Biochemistry and Microbiology, University of Victoria, British Columbia, V8P 5C2, Canada.

Funding

Translational Incubator CoreU19AI109662 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2014 to 2019
$28.6M
RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
The PIP2-virus interface and PI 4-kinase: novel biology and validation targetsR01AI099245 · NIAID · STANFORD UNIVERSITY · PI GLENN, JEFFREY S · 2012 to 2016
$5.2M
British Heart Foundation PG/11/109/29247British Heart Foundation PG11/109/29247CIHRMedical Research Council MC_U105184308Medical Research Council U10518430NIAID NIH HHS AI099245NIAID NIH HHS AI109622NIAID NIH HHS R01 AI099245NIAID NIH HHS U19 AI109662NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

The ability of proteins to bind and interact with protein partners plays fundamental roles in many cellular contexts. X-ray crystallography has been a powerful approach to understand protein-protein interactions; however, a challenge in the crystallization of proteins and their complexes is the presence of intrinsically disordered regions. In this article, we describe an application of hydrogen deuterium exchange mass spectrometry (HDX-MS) to identify dynamic regions within type III phosphatidylinositol 4 kinase beta (PI4KIIIβ) in complex with the GTPase Rab11. This information was then used to design deletions that allowed for the production of diffraction quality crystals. Importantly, we also used HDX-MS to verify that the new construct was properly folded, consistent with it being catalytically and functionally active. Structures of PI4KIIIβ in an Apo state and bound to the potent inhibitor BQR695 in complex with both GTPγS and GDP loaded Rab11 were determined. This hybrid HDX-MS/crystallographic strategy revealed novel aspects of the PI4KIIIβ-Rab11 complex, as well as the molecular mechanism of potency of a PI4K specific inhibitor (BQR695). This approach is widely applicable to protein-protein complexes, and is an excellent strategy to optimize constructs for high-resolution structural approaches.

Indexed as

Binding SitesCatalytic DomainCrystallography, X-RayDeuterium Exchange MeasurementHumansMass SpectrometryModels, MolecularPhosphotransferases (Alcohol Group Acceptor)Protein BindingProtein Conformationrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsPhosphotransferases (Alcohol Group Acceptor)PI4KB protein, humanrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsHDX-MShydrogen deuterium exchange mass spectrometrylipid signalingphosphatidylinositol 4 kinasephosphoinositide signalingRab11structural biologyX-ray crystallography

Identifiers

PMID26756197
PMCPMC4832280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.